Numbers of new patient accruals and newly activated trials decreased early on, followed by progressive recovery
Another HIV Vaccine Trial Canceled Due to Poor Results
Cancellation is the latest in a string of failures for HIV vaccine research
Enrollment in Cancer Treatment Trials Largely Unchanged by Pandemic
However, there was a significant decrease in enrollment for cancer control and prevention trials
Should Changes Made to Clinical Trials During Pandemic Be Kept?
Changes were recommended to preserve potential patient benefit while minimizing risks associated with COVID-19
NIH Starts Trial Assessing ‘Mix & Match’ COVID-19 Vaccine Approach
Individuals who received J&J, Moderna, or Pfizer-BioNTech vaccine will receive single booster dose of Moderna vaccine 12 to 20 weeks later
NIH Halts Trial of Convalescent Plasma for Mild COVID-19
While the treatment seemed safe, no significant differences in outcomes were seen between patients receiving convalescent plasma or placebo
COVID-19 Vaccines Adapted to Fight Variants Will Not Require Long Clinical Trials: FDA
Most makers of approved COVID-19 vaccines have said they plan to adapt their vaccines to tackle variants
Oncology Clinical Trials Decline During Pandemic
Decline in trial launches could have long-term negative impact, authors say
Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS
Researchers explore possible anti-inflammatory effects of mesenchymal stem cells in COVID-19 acute respiratory distress syndrome
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
U.S. Food and Drug Administration authorized the restart after reviewing all safety data
- Page 1 of 2
- 1
- 2